Overview

A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye

Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety and efficacy of lifitegrast ophthalmic solution compared to placebo in the treatment of dry eye.
Phase:
Phase 3
Details
Lead Sponsor:
Shire
Treatments:
Lifitegrast
Ophthalmic Solutions
Pharmaceutical Solutions